News and events
Read about the latest developments at NorthX Biologics and find out more about relevant happenings in the industry.
Lipum AB (Publ), a clinical stage biopharmaceutical company specialized in discovery and
development of a novel treatment for chronic inflammatory diseases today announces that
it has entered into a manufacturing alliance with NorthX Biologics AB, a Contract
Development and Manufacturing Organisation (CDMO).
Leiden, The Netherlands - February 19, 2024 - Synerkine Pharma, a Dutch biopharmaceutical company creating innovative pain solutions, today announced a manufacturing alliance with NorthX Biologics AB, a leading biopharmaceutical company committed to pioneering solutions in gene therapy and biotechnology. The alliance will support Synerkine’s development portfolio, including its most advanced program SK-01, a cytokine-cytokine fusion protein combining the effects of IL-4 and IL-10 as a treatment option for chronic pain. SK-01 is progressing steadily toward clinical development with complex regional pain syndrome (CRPS), a severe chronic pain indication, as the lead indication.
MATFORS, Sweden, Nov. 01, 2023 (GLOBE NEWSWIRE) -- NorthX Biologics AB, a pioneer in biopharmaceutical innovation, is excited to announce the launch of its proprietary plasmids for the efficient manufacture of AAV (Adeno-Associated Virus) vectors for gene therapy. This strategic expansion complements NorthX's existing GMP and non-GMP plasmid and viral vector production capabilities, allowing the company to offer end-to-end support to gene therapy companies, from sequence design to the final release of AAV gene therapy product.
This article is written by NorthX Biologics Senior Advisor Helena Strigård och Bio-works Technologies CEO Jonathan Royce.
Nu kan man läsa den spännande artikeln om innovationsfabriken på Dagens Industri.
We are proud to inform you that NorthX Biologics improved its score from bronze to silver in the International Sustainability Survey (EcoVadis) for year 2022!
Conference "Advanced Biologics in Matfors and Beyond" at NorthX Bio went to a big success!
NorthX Biologics appoints industry veterans to its board of directors
Idag kan vi meddela att vi expanderar inom produktion av cellterapi bl.a. via partnerskap med Alder Therapeutics samt att vi expanderar med en andra tillverkningsanläggning på Karolinska.
2022-06-21